分娩住院期间克林霉素与庆大霉素相关感染及肾损伤风险
基于2006年1月至2015年3月住院行政数据库,分析分娩住院孕产妇中克林霉素相关艰难梭菌感染与庆大霉素相关急性肾损伤的风险。克林霉素组艰难梭菌感染率0.04%,风险约为其他抗生素组的2.93倍;庆大霉素组急性肾损伤率0.24%,风险约为其他抗生素组的3.01倍,但绝对风险较低。
要点
- 克林霉素与艰难梭菌感染风险升高相关(RR 2.93,99%CI 2.21-3.90)。
- 庆大霉素与急性肾损伤风险升高相关(RR 3.01,99%CI 2.62-3.45)。
- 子痫前期妇女使用庆大霉素急性肾损伤风险亦升高(RR 2.04,99%CI 1.64-2.53)。
核心结论
- 克林霉素与艰难梭菌感染风险显著增加相关,庆大霉素与急性肾损伤风险显著增加相关,但绝对风险较低。
研究设计与样本
- 基于住院行政数据库的队列分析,纳入2006年1月至2015年3月分娩住院的5,657,523名妇女。
主要发现
- 克林霉素组艰难梭菌感染率为0.04%,风险约为其他抗生素组的2.93倍(RR 2.93,99%CI 2.21-3.90)。
- 庆大霉素组急性肾损伤率为0.24%,风险约为其他抗生素组的3.01倍(RR 3.01,99%CI 2.62-3.45)。
- 未使用抗生素组急性肾损伤风险显著低于其他抗生素组(RR 0.18,99%CI 0.15-0.20)。
- 子痫前期妇女使用庆大霉素急性肾损伤风险升高(RR 2.04,99%CI 1.64-2.53)。
- 调整患者人口学、分娩方式及医院特征后,上述关联仍显著。
临床怎么用
- 分娩住院期间使用克林霉素或庆大霉素时,需关注艰难梭菌感染及急性肾损伤风险,尤其子痫前期患者。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To describe risk of Clostridium difficile infection associated with clindamycin and acute kidney injury associated with gentamicin during delivery hospitalizations. METHODS: Women admitted for delivery from January 2006 to March 2015 were analyzed using an inpatient administrative database. Primary outcomes were C difficile infection and acute kidney injury. C difficile infection was compared between women receiving clindamycin (with or without other antibiotics) and women receiving antibiotics other than clindamycin. Acute kidney injury was compared between women receiving gentamicin (with or without other antibiotics), women receiving antibiotics other than gentamicin, and women receiving no antibiotics. Unadjusted and adjusted log linear models analyzing the role of patient demographics, mode of delivery, and hospital-level characteristics were created evaluating risk of C difficile infection and acute kidney injury with risk ratios (RRs) and adjusted risk ratios with 99% CIs as measures of association. A sensitivity analysis for gentamicin and acute kidney injury was performed restricted to women with preeclampsia. RESULTS: Of 5,657,523 women admitted for delivery hospitalization, 266,402 (4.7%) received clindamycin and 165,726 (2.9%) received gentamicin. C difficile infection was diagnosed in 0.04% of women receiving clindamycin. Compared with women receiving other antibiotics, clindamycin was associated with a nearly threefold increased risk of C difficile infection (RR 2.93, 99% CI 2.21-3.90). Acute kidney injury was diagnosed in 0.24% of women receiving gentamicin. Gentamicin was associated with a threefold increased risk of acute kidney injury (RR 3.01, 99% CI 2.62-3.45) compared with women receiving other antibiotics, whereas receipt of no antibiotics was associated with significantly lower risk (RR 0.18, 99% CI 0.15-0.20). In adjusted analyses, these associations retained significance. Significantly increased risk of acute kidney injury was noted for women with preeclampsia receiving gentamicin (RR 2.04, 99% CI 1.64-2.53). CONCLUSION: Receipt of clindamycin was associated with significantly increased likelihood for C difficile infection and receipt of gentamicin with significantly increased likelihood of acute kidney injury, although the absolute risk of these complications was low.
引用
- Duffy CR, Huang Y, Andrikopoulou M, et al. Clindamycin, Gentamicin, and Risk of Clostridium difficile Infection and Acute Kidney Injury During Delivery Hospitalizations. Obstet Gynecol. 2020. PMID: 31809424. doi:10.1097/AOG.0000000000003568
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。